Transcranial ultrasonic stimulation system and method supporting interval and frequency modulation

By designing a transcranial ultrasound stimulation system that supports interval and frequency regulation, the problems of difficult equipment operation and difficult parameter regulation are solved, and effective recovery of cognitive dysfunction after stroke is achieved, and multi-parameter regulation and high-precision signal control are met. Demand, reducing treatment costs.

CN118925100APending Publication Date: 2024-11-12FUDAN UNIVERSITY
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411078302.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing transcranial ultrasound stimulation equipment has problems such as high learning cost, high operational difficulty, difficult parameter regulation, low spatial resolution, fixed output parameters or limited power, and it is difficult to meet the rehabilitation needs of cognitive dysfunction after stroke.

Method used

A transcranial ultrasonic stimulation system supporting interval and frequency regulation is designed, including upper computer interaction module, programmable logic module, ultrasonic emission module and power module. The precise adjustment of ultrasonic signal parameters is achieved through the GUI interface, and the intelligent parameter selection mode is adopted. and autonomous setting mode, supporting multi-parameter adjustment, including waveform, frequency, phase, amplitude, stimulation duration and interval stimulation mode, which can realize high-precision signal control and fine multi-speed voltage adjustment.

Benefits of technology

It realizes a portable, easy to operate, and multi-parameter adjustable transcranial ultrasound stimulation system, which can effectively recover cognitive dysfunction after stroke, meet the needs of low-intensity neuroregulatory experiments, reduce treatment costs, and improve treatment effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118925100A_ABST
    Figure CN118925100A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of ultrasonic stimulation, and provides a transcranial ultrasonic stimulation system supporting interval and frequency modulation. The upper computer interaction module is used for generating control data serving as high-precision signals according to excitation ultrasonic signal parameters, and the excitation ultrasonic signals are configured in a mode including an intelligent parameter selection mode and an autonomous setting mode; the programmable logic module is used for receiving control data, completing generation and configuration of waveform data and control signals and then sequentially sending the waveform data into the ultrasonic transmitting module according to a fixed frequency; the ultrasonic transmitting module is used for carrying out digital-to-analog conversion on waveform data, amplifying the waveform data through an ultrasonic linear amplification chip and then loading the waveform data to an ultrasonic transducer for outputting; and the power supply module provides a plurality of working levels required in the working process of the system, provides high voltage required by the high-voltage ultrasonic pulse, and performs fine multi-gear adjustment on the voltage. Interval stimulation and frequency modulation ultrasonic stimulation are supported, and the frequency, pulse repetition frequency, duty ratio and the like of output ultrasound are accurately adjusted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of ultrasonic stimulation, and in particular to a transcranial ultrasonic stimulation system and method supporting interval and frequency modulation. Background Art

[0002] According to statistics, the probability of post-stroke cognitive impairment (PSCI) in stroke patients is about one-third. The mortality rate of PSCI patients is significantly higher than that of patients without cognitive impairment. The cognitive impairment of PSCI patients will seriously affect the quality of life, and the mental health of patients will be significantly reduced, further increasing the disease burden on families and society. In clinical practice, the treatment of PSCI mainly involves three aspects: drug therapy, treatment of psychiatric and behavioral symptoms, and rehabilitation therapy. However, each of these treatment methods has its limitations. For example, long-term use of drugs may have safety and tolerability issues, and treatment of psychiatric and behavioral symptoms is more suitable for early mild stages, while rehabilitation therapy requires a lot of manpower and material costs. In addition, since the specific pathogenesis of PSCI is still unclear, it has brought great difficulties to the prognosis and rehabilitation of PSCI. Therefore, a safe, low-side-effect, and low-cost treatment method is urgently needed.

[0003] As a non-invasive brain regulation technology, transcranial ultrasound stimulation (TUS) has gradually become the focus and hotspot in the field of neuroregulation research due to its advantages of non-invasive safety, high spatial resolution, deep penetration and easy synchronization with neuroimaging. Studies in recent years have confirmed that transcranial ultrasound stimulation can have an excitatory or inhibitory effect on cortical excitability according to different combinations of its frequency, intensity and modulation mode. A large number of experiments have also proved the application value of transcranial ultrasound in neuroregulation. Transcranial ultrasound stimulation has feasibility and application potential in promoting cognitive function improvement after ischemic stroke, but research in this field has not yet been fully carried out and still needs further in-depth exploration and experimental verification.

[0004] The widely used transcranial ultrasound stimulation devices are assembled from waveform generators, power amplifiers and general transducers. For users without electronic backgrounds, they have high learning costs and difficulty in operation, and parameters are difficult to adjust and lack flexibility. Existing commercial ultrasound stimulation devices are mostly used for physical therapy, have low spatial resolution, and often have problems with fixed output parameters or limited output power. Commercial ultra-high-resolution transcranial focused ultrasound stimulation devices are expensive and difficult to use in large quantities.

[0005] Therefore, it is of great social and economic significance to design a transcranial ultrasound stimulation system that is portable, easy to operate, multi-parameter adjustable, multi-channel, and highly reliable, to achieve the ultrasonic stimulation mode required for experimental research, to explore a simple and effective rehabilitation method, and to promote the improvement of cognitive function after ischemic stroke. Summary of the invention

[0006] In response to the above problems, the purpose of the present invention is to provide a transcranial ultrasound stimulation system and method that supports interval and frequency modulation, supports interval stimulation and frequency-modulated ultrasound stimulation, is used to promote the rehabilitation of cognitive dysfunction after stroke, and can accurately adjust multiple parameters such as the output ultrasound frequency, pulse repetition frequency, duty cycle, etc.

[0007] The above-mentioned object of the present invention is achieved through the following technical solutions:

[0008] A transcranial ultrasound stimulation system supporting interval and frequency modulation, comprising: a host computer interaction module, a programmable logic module, an ultrasound transmission module and a power supply module;

[0009] The host computer interaction module is used to receive the excitation ultrasonic signal parameters of the custom configuration, and generate control data as a high-precision signal according to the excitation ultrasonic signal parameters, and transmit it to the programmable logic module, wherein the custom configuration of the excitation ultrasonic signal is configured in a manner including an intelligent parameter selection mode and an autonomous setting mode;

[0010] The programmable logic module is used to receive the control data transmitted by the host computer interaction module, and after completing the generation and configuration of the waveform data and the control signal according to the control data, send the waveform data to the ultrasonic transmitting module in sequence at a fixed frequency;

[0011] The ultrasonic transmitting module is used to complete the digital-to-analog conversion of the waveform data, and after amplification by the ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output;

[0012] The power supply module is used to provide multiple operating levels required during the operation of the system, provide the high voltage required for the high-voltage ultrasonic pulse, and perform fine multi-level voltage regulation.

[0013] Furthermore, in the host computer interaction module, the excitation ultrasonic signal parameters of the custom configuration are received, and the control data as the high-precision signal is generated according to the excitation ultrasonic signal parameters, and transmitted to the programmable logic module, specifically:

[0014] Providing a GUI interface for inputting the excitation ultrasound signal parameters, and adjusting the excitation ultrasound signal parameters including waveform, frequency, phase, amplitude, stimulation duration, output duration and interval duration of the interval stimulation mode through the GUI interface;

[0015] After converting the excitation ultrasonic signal parameters into the control data, the data are transmitted to the programmable logic module via a serial peripheral interface UART protocol;

[0016] The host computer interaction module displays the waveform sampling situation to adjust the excitation ultrasonic signal parameters according to the waveform sampling situation.

[0017] Furthermore, in the host computer interaction module, the intelligent parameter selection mode is used to set the excitation ultrasonic signal parameters, specifically:

[0018] A: Building a treatment database:

[0019] Collecting data: collecting experimental data and test results before and after treatment with different combinations of the excitation ultrasound signal parameters, including optical imaging results, neurological function scores, staining results, and inflammation reduction degrees;

[0020] Establishing a scoring mechanism: setting scoring weights according to different indicators including the degree of inflammation relief, tissue recovery and pathological staining, and giving a treatment effect score for each combination of the excitation ultrasound signal parameters;

[0021] B: Data Analysis

[0022] Severity determination: The severity of the patient is determined based on optical imaging results, modified neurological function assessment, and corner test, and is divided into three categories: mild, moderate, and severe;

[0023] Indicator weight setting: Setting weights for different treatment effect indicators including the degree of inflammation reduction, tissue recovery and pathological staining;

[0024] Score calculation: calculating the comprehensive score of the corresponding combination of the excitation ultrasonic signal parameters according to the experimental data;

[0025] C: Parameter selection

[0026] Test data input: Input the patient's test data, including optical imaging results, behavioral experiment results, and neurological function scores;

[0027] Score matching: matching the combination of the excitation ultrasound signal parameters in the treatment database according to the input data, and selecting the combination of the excitation ultrasound signal parameters with the highest score.

[0028] Furthermore, the severity determination is specifically as follows:

[0029] The optical imaging result: the photoacoustic signal intensity of the damaged area before and after the damage is analyzed, and the photoacoustic signal intensity of the damaged area before the damage is used as the reference value, and the photoacoustic signal attenuation degree of the damaged area after the damage is calculated as |Iafter damage-Ibefore damage| / Ibefore damage*100%;

[0030] The improved neurological function assessment: conducting experiments on neurological deficits including tail lifting test, walking test, sensory test, balance beam test, reflex and abnormal movement, scoring different test results respectively and accumulating them;

[0031] The corner turning test is used to evaluate sensorimotor disorders caused by unilateral or asymmetric striatal damage, measure asymmetric sensorimotor disorders and detect unilateral abnormalities of sensory and motor functions in ischemic stroke models. Several consecutive corner turning tests are performed. The CT score of the corner turning test = [R / (R+L)] × 100%, where R is the number of right turns; L is the number of left turns;

[0032] The severity is classified into three categories: mild, moderate and severe, based on a comprehensive judgment made according to the optical imaging results, the modified neurological function assessment and the weight of the angle test.

[0033] Furthermore, in the host computer interaction module, the excitation ultrasonic signal parameters are set in an autonomous setting mode, specifically:

[0034] Performing autonomous parameter setting on the GUI interface provided by the host computer interaction module;

[0035] Among them, the target frequency f_wave is the ultrasonic frequency of the excitation, the minute setting and the second setting are the minutes and seconds corresponding to the total stimulation duration, PRF is the pulse repetition frequency, DC is the duty cycle, waketime and sleep time correspond to the output duration and interval duration in the interval stimulation mode respectively, gain1 and gain0 correspond to the gain control of the two-stage amplifier circuit in the ultrasonic linear amplifier circuit, where gain1 represents high gain and gain0 represents low gain. The size of the quantized waveform data is controlled by setting wave_amp;

[0036] At the same time, the autonomous setting mode includes a fixed frequency ultrasonic output mode and a frequency modulation ultrasonic output mode. The target frequency of the fixed frequency ultrasonic output mode is a fixed value, and the target frequency of the frequency modulation ultrasonic output mode needs to set the initial frequency f0 and the end frequency fe, as well as the duration of a cycle.

[0037] Furthermore, the ultrasonic transmitting module includes a digital-to-analog converter, an ultrasonic linear power amplifier, an impedance matching device and an ultrasonic transducer;

[0038] The digital-to-analog conversion is used to complete the digital-to-analog conversion of the waveform data, the ultrasonic linear power amplifier is used to perform ultrasonic linear amplification on the waveform data, the impedance matching is used to ensure the impedance matching between the signal source of the waveform data and the ultrasonic transducer as a load, and the ultrasonic transducer is used to finally output the generated ultrasound;

[0039] Among them, the ultrasonic linear power amplifier includes a low-voltage signal buffer, a high-voltage linear amplifier, a feedback circuit and a protection circuit. The low-voltage signal buffer receives the signal from the programmable logic module, adopts a high input impedance amplifier to prevent signal detail loss, and adjusts the amplification factor to 2 or 4 times by adjusting the low gain gain0. The high-voltage linear amplifier uses a linear amplification circuit to provide high-quality signal amplification and required power output. The amplification factor is adjusted to 6 or 46 times by adjusting the high gain gain1. The feedback circuit is used to stabilize the output. The protection circuit includes overcurrent and overheating protection circuits to prevent damage to the power amplifier.

[0040] Furthermore, the power supply module includes a low-voltage power supply and a high-voltage programmable power supply;

[0041] The low-voltage power supply is used to provide multiple working levels required during the operation of the system, and the high-voltage programmable power supply is controlled by an external control voltage or program code to provide the high voltage required for high-voltage ultrasonic pulses and to finely adjust the voltage in multiple levels.

[0042] A method for transcranial ultrasound stimulation supporting interval and frequency modulation using the above-mentioned transcranial ultrasound stimulation system supporting interval and frequency modulation comprises the following steps:

[0043] S1: The upper computer interaction module receives the excitation ultrasonic signal parameters configured by the user, generates control data as a high-precision signal according to the excitation ultrasonic signal parameters, and transmits the control data to the programmable logic module, wherein the excitation ultrasonic signal is configured by the user-defined configuration in a manner including an intelligent parameter selection mode and an autonomous setting mode;

[0044] S2: the programmable logic module receives the control data transmitted by the host computer interaction module, generates and configures the waveform data and the control signal according to the control data, and then sends the waveform data to the ultrasonic transmitting module in sequence at a fixed frequency;

[0045] S3: The ultrasonic transmitting module completes the digital-to-analog conversion of the waveform data, and after amplification by the ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output, and a power supply module is used to provide multiple working levels required during the operation of the system, as well as the high voltage required for high-voltage ultrasonic pulses, and the voltage is finely adjusted in multiple gears.

[0046] A computer device comprises a memory and one or more processors, wherein the memory stores computer codes, and when the computer codes are executed by the one or more processors, the one or more processors execute the above method.

[0047] A computer-readable storage medium stores computer codes. When the computer codes are executed, the above method is executed.

[0048] Compared with the prior art, the present invention has the following beneficial effects:

[0049] By providing a transcranial ultrasound stimulation system that supports interval and frequency modulation, and supports multi-parameter adjustment including intelligent parameter selection mode and autonomous setting mode for interval stimulation and frequency modulation ultrasound stimulation, it is used to promote the rehabilitation of cognitive dysfunction after stroke. The system can use high-precision signals to precisely control the output dose of ultrasound, and can accurately adjust the parameters such as ultrasound center frequency, pulse repetition frequency, duty cycle, etc. in multiple gears, and can achieve interval stimulation and frequency modulation ultrasound stimulation within a certain frequency range, which can meet the needs of low-intensity transcranial ultrasound neural regulation experimental exploration. At the same time, the power module can finely adjust the high voltage required for high-voltage ultrasound pulses in multiple gears. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 The overall structure diagram of the transcranial ultrasound stimulation system supporting interval and frequency modulation of the present invention;

[0051] Figure 2 A flowchart of the actual treatment of a patient by the present invention;

[0052] Figure 3 This is a schematic diagram of the GUI interface of the present invention;

[0053] Figure 4 It is a structural block diagram of the ultrasonic linear power amplifier of the present invention;

[0054] Figure 5 It is a schematic diagram of the effectiveness of the system of the present invention;

[0055] Figure 6 It is an overall flow chart of the transcranial ultrasound stimulation method supporting interval and frequency modulation of the present invention;

[0056] Figure 7 Schematic diagram of the mouse of the present invention before and after injury;

[0057] Figure 8 It is a schematic diagram of the transcranial ultrasound control experiment and parameters of the present invention;

[0058] Fig. 9 It is a schematic diagram of the movement distance of different groups in the open arm after transcranial ultrasound stimulation of the present invention;

[0059] Fig.10 Schematic diagram of inflammatory cell infiltration in different groups after transcranial ultrasound stimulation of the present invention;

[0060] Fig.11It is a schematic diagram of cell shrinkage and dark staining in different groups after transcranial ultrasound stimulation of the present invention;

[0061] Fig.12 This is a schematic diagram of BDNF expression levels in different groups after transcranial ultrasound stimulation of the present invention;

[0062] Fig.13 This is a schematic diagram of the Iba1 expression levels in different groups after transcranial ultrasound stimulation of the present invention. DETAILED DESCRIPTION

[0063] In order to make the purpose, technical solution and advantages of the embodiments of the present application clearer, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0064] Those skilled in the art will appreciate that, unless otherwise stated, the singular forms "a", "an", "said" and "the" used herein may also include plural forms. It should be further understood that the term "comprising" used in the specification of the present invention refers to the presence of the features, integers, steps, operations, elements and / or components, but does not exclude the presence or addition of one or more other features, integers, steps, operations, elements, components and / or groups thereof.

[0065] First embodiment

[0066] like Figure 1 As shown, this embodiment provides a transcranial ultrasound stimulation system supporting interval and frequency modulation, including: a host computer interaction module, a programmable logic module, an ultrasound transmission module and a power supply module;

[0067] The host computer interaction module is used to receive the custom-configured excitation ultrasonic signal parameters, and generate control data as a high-precision signal based on the excitation ultrasonic signal parameters, and transmit it to the programmable logic module, wherein the custom-configured excitation ultrasonic signal is configured in a manner including an intelligent parameter selection mode and an autonomous setting mode; the programmable logic module is used to receive the control data transmitted by the host computer interaction module, and after completing the generation and configuration of waveform data and control signals based on the control data, the waveform data is sequentially sent to the ultrasonic transmitting module at a fixed frequency; the ultrasonic transmitting module is used to complete the digital-to-analog conversion of the waveform data, and after amplification by an ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output; the power supply module is used to provide multiple working levels required during the operation of the system, as well as provide the high voltage required for high-voltage ultrasonic pulses, and perform fine multi-level voltage adjustment.

[0068] Specifically, the human-computer interaction realized by the host computer interaction module of the present invention is realized by the user operating the computer interaction software, configuring the parameters of the excitation ultrasonic signal on the MATLAB program interface, and the parameters input by the user on the PC host computer interaction interface are converted into control data, and the transmission to the programmable logic module FPGA is realized through the serial peripheral interface protocol (UART protocol). The PC host computer interaction module mainly realizes the configuration and processing of the parameters such as the waveform, frequency, amplitude, and total stimulation duration of the ultrasonic wave. The MATLAB program carried on the PC host computer processes the parameters to be configured with the powerful computing power of the CPU, and sends the corresponding data to the programmable logic module FPGA according to the agreed transmission protocol. The low-voltage power supply module provides multiple working levels required during the system operation process, and the high-voltage power supply module can be controlled by an external control voltage or program coding, and is used to provide the high voltage required for the high-voltage ultrasonic pulse, and finely adjust the voltage in multiple gears. The system workflow is that the user configures the corresponding parameters on the PC host computer. After the input is completed, it communicates with the programmable logic module FPGA through the UART communication protocol, passes the instructions transmitted from the PC host computer to the FPGA for processing, and completes the generation and configuration of waveform data and control signals in the FPGA. After that, the waveform data is sent to the high-speed digital-to-analog converter in sequence at a fixed frequency, amplified by the ultrasonic linear amplifier chip, and loaded onto the transducer for output. The host computer is also equipped with an intelligent parameter selection system. Based on the test results, by building a treatment database, combined with experimental data and subsequent treatment effects, it gives scores for different parameter combinations and intelligently selects the optimal treatment parameter combination.

[0069] Advantages of host computer signal generation: In common ultrasonic equipment, ultrasonic signal generation mostly adopts Direct Digital Synthesis (DDS) technology, which is based on the sampling theorem. First, the waveform to be generated is sampled, and the sampled value is digitized and stored in the memory as a lookup table. Then the data is read through the lookup table, and then converted into an analog signal by a digital-to-analog converter, and the saved waveform is resynthesized. The traditional DDS is mainly composed of a standard reference frequency source (stable clock), a phase accumulator, a waveform memory, a digital-to-analog converter, a low-pass smoothing filter, etc., and a clock is used to drive a programmable read-only memory that stores one or more integer cycles of a sine wave (or other arbitrary waveform). As the address counter executes each memory location step by step, the digital amplitude of the signal corresponding to each location drives the digital-to-analog converter to generate an analog output signal.

[0070] For traditional DDS technology, the waveform data stored in the memory is fixed or needs to be re-burned if it is changed, which lacks flexibility. If you want to change the frequency of the output signal, you often need to change the frequency of the clock CLOCK of the table lookup addressing or change the addressing step size. However, accurately changing the clock frequency requires more resources in system design, and changing the addressing step size will reduce the accuracy of the waveform.

[0071] This system is improved based on the traditional DDS technology. Through the MATLAB program written in the host computer and the good GUI interface, the waveform, frequency, phase, amplitude and other parameters of the ultrasonic signal can be quickly adjusted according to different output requirements, and quickly transmitted to the hardware circuit. Not only limited to simple waveforms such as sine waves and square waves, relying on the powerful floating-point computing capabilities of the computer, it can also generate frequency-modulated waves and even specific waveforms required in special systems very accurately, effectively solving the problem of waveform accuracy reduction caused by changing the frequency in traditional DDS technology. At the same time, the system can display the sampling of the waveform, which is convenient for parameter adjustment. The system can also adjust the sampling frequency according to the model of the digital-to-analog converter used. MATLAB provides a wealth of interfaces that can be easily integrated with other software and hardware systems, with high scalability and ease of operation.

[0072] The present invention realizes fine multi-level adjustment of voltage: common ultrasonic therapeutic equipment, such as the ultrasonic therapeutic devices WED-100 and WED-200 produced by Shenzhen Wilder Medical Electronics Co., Ltd., are equipped with fixed ultrasonic transducers, and their output frequency and coverage range are also fixed. The equipment parameter adjustment is to adjust the output power, which is difficult to meet diverse needs.

[0073] Since the ultrasonic transducers equipped in this system have various specifications and different conversion efficiencies, there is no fixed gear for adjusting different output sound intensities. It is achieved by adjusting the voltage loaded on the ultrasonic transducer. The voltage adjustment range of this system is 10-180V, and the output control accuracy can reach 0.5V. Multi-level fine adjustment is achieved through the control module. Specifically, the waveform signal is generated in the host computer and sampled according to the maximum update rate of the digital-to-analog converter of 125MHz (which can be upgraded to a model with a higher maximum update rate), with a sampling accuracy of 10 bits (2 10 =1024 corresponds to voltage ±1V), a high-precision digital-to-analog converter and a power amplifier are used in the hardware circuit, and the amplitude of the quantized waveform can be adjusted by the gain control coefficient wave_amp. The voltage output v_out of the digital-to-analog converter is v*wave_amp, and the power amplifier is a two-stage amplification architecture, including a low-voltage signal buffer (2 or 4 times) and a high-voltage linear amplifier (6 or 46 times). By adjusting the gain control coefficient wave_amp and controlling the amplification factors of the low-voltage signal buffer and the high-voltage linear amplifier through gain0 and gain1, the ultrasonic signal can be converted into the required voltage output, and the voltage can be finely adjusted in multiple gears. The maximum output power of a single channel of the system can reach 45W.

[0074] The invention of the present invention is described in detail below according to the modules:

[0075] In the host computer interaction module, custom configured excitation ultrasonic signal parameters are received, and the excitation ultrasonic signal parameters are converted into control data and transmitted to the programmable logic module, specifically: a GUI interface for inputting the excitation ultrasonic signal parameters is provided, and the excitation ultrasonic signal parameters including waveform, frequency, phase, amplitude, stimulation duration, output duration and interval duration of interval stimulation mode are adjusted through the GUI interface; after converting the excitation ultrasonic signal parameters into the control data, they are transmitted to the programmable logic module through the serial peripheral interface UART protocol; the host computer interaction module displays the waveform sampling situation to adjust the excitation ultrasonic signal parameters according to the waveform sampling situation.

[0076] In the host computer interaction module, the excitation ultrasonic signal parameters are set in an intelligent parameter selection mode or an autonomous setting mode, specifically:

[0077] (1) Intelligent parameter selection mode

[0078] Design of intelligent parameter selection system: The intelligent parameter selection system is based on the results of photoacoustic imaging, neurological function scoring, corner test, etc. before treatment, as well as the results of plasma inflammatory factor detection, pathological staining scoring, protein blot detection, immunofluorescence staining quantitative analysis, etc. after treatment. By building a treatment database, combined with experimental data and subsequent effects, the severity and degree of improvement of the patient are judged, and the scoring weights of different parameter combinations are given. The system intelligently recommends the optimal treatment parameter combination under the current conditions based on the treatment effect scores in the database.

[0079] Specific implementation steps:

[0080] A: Building a treatment database:

[0081] Collecting data: collecting experimental data and test results before and after treatment with different combinations of the excitation ultrasound signal parameters, including optical imaging results, neurological function scores, staining results, and inflammation reduction degrees;

[0082] A scoring mechanism is established: scoring weights are set according to different indicators including the degree of inflammation relief, tissue recovery and pathological staining, and a treatment effect score is given for each combination of the excitation ultrasound signal parameters.

[0083] B: Data Analysis

[0084] Severity determination: The severity of the patient is determined based on optical imaging results, modified neurological function assessment, and corner test, and is divided into three categories: mild, moderate, and severe;

[0085] Indicator weight setting: weights are set for different treatment effect indicators including inflammation reduction, tissue recovery and pathological staining, such as inflammation reduction 40%, tissue recovery 40%, and pathological staining 20%;

[0086] Score calculation: Calculate the comprehensive score of the corresponding combination of the excitation ultrasonic signal parameters based on the experimental data.

[0087] C: Parameter selection

[0088] Test data input: Input the patient's test data, including optical imaging results, behavioral experiment results, and neurological function scores;

[0089] Score matching: matching the combination of the excitation ultrasound signal parameters in the treatment database according to the input data, and selecting the combination of the excitation ultrasound signal parameters with the highest score.

[0090] like Figure 2As shown in the figure, when it is necessary to actually treat a patient, the patient's test data is first input, and the scores of all combinations of excitation ultrasound signal parameters are calculated based on the test data. The combination of excitation ultrasound signal parameters with the highest score is selected for treatment. After the treatment, the treatment effect is fed back and the database is updated. By constructing a treatment database, setting a scoring mechanism and an intelligent matching algorithm, the system can select the optimal combination of treatment parameters based on the patient's test data and provide a personalized treatment plan. This method can improve the treatment effect and achieve dynamic adjustment and optimization.

[0091] The severity determination is specifically as follows:

[0092] 1. The optical imaging results: The photoacoustic signal intensity of the damaged area before and after the damage was analyzed, and the photoacoustic signal intensity of the damaged area before the damage was used as the reference value, and the photoacoustic signal attenuation degree of the damaged area after the damage was calculated as |Iafter damage-Ibefore damage| / Ibefore damage*100%.

[0093] 2. The modified neurological function assessment: conduct experiments on neurological deficits including tail lifting test, walking test, sensory test, balance beam test, reflex and abnormal movement, and score different test results respectively and accumulate them. For example, the total score is 0-18 points: 13-18 points indicate severe damage; 7-12 points indicate moderate damage; 1-6 points indicate mild damage. The scoring table is shown in Table 1 below.

[0094]

[0095]

[0096] 3. The corner turning test is used to evaluate sensorimotor impairment caused by unilateral or asymmetric striatal damage, measure asymmetric sensorimotor impairment, and detect unilateral abnormalities in sensory and motor function in ischemic stroke models.

[0097] For example, the corner turning test apparatus consists of two vertical plates connected at a 30° angle. A total of 10 consecutive trials were performed with approximately 30 seconds of rest between trials. Non-ischemic mice had an equal probability of turning left or right, but ischemic mice preferentially turned to the uninjured ipsilateral side (right side). CT score = [R / (R+L)] × 100% R: right turn; L: left turn.

[0098] 4. Severity judgment: Based on the weights of the optical imaging results, the modified neurological function assessment and the corner test, the severity is divided into three categories: mild, moderate and severe. For example, based on the comprehensive judgment of 50% of the photoacoustic imaging results, 30% of the modified neurological function score and 20% of the corner test, the severity is divided into three categories: mild, moderate and severe.

[0099] (2) Self-setting mode

[0100] Performing autonomous parameter setting on the GUI interface provided by the host computer interaction module;

[0101] Among them, the target frequency f_wave is the ultrasonic frequency of the excitation, the minute setting and the second setting are the minutes and seconds corresponding to the total stimulation duration, PRF is the pulse repetition frequency, DC (Duty Cycle) is the duty cycle, wake time and sleep time correspond to the output duration and interval duration in the interval stimulation mode respectively, gain1 and gain0 correspond to the gain control of the two-stage amplifier circuit in the ultrasonic linear amplifier circuit, where gain1 represents high gain and gain0 represents low gain. The size of the quantized waveform data is controlled by setting wave_amp;

[0102] At the same time, the autonomous setting mode includes a fixed frequency ultrasonic output mode and a frequency modulation ultrasonic output mode. The target frequency of the fixed frequency ultrasonic output mode is a fixed value, and the target frequency of the frequency modulation ultrasonic output mode needs to set the initial frequency f0 and the end frequency fe, as well as the duration of a cycle. Figure 3 As shown, the left side is a schematic diagram of a fixed frequency ultrasonic output mode, and the right side is a schematic diagram of a frequency modulated ultrasonic output mode.

[0103] The ultrasonic transmitting module includes a digital-to-analog converter, an ultrasonic linear power amplifier, an impedance matching module and an ultrasonic transducer; the digital-to-analog converter is used to complete the digital-to-analog conversion of the waveform data, the ultrasonic linear power amplifier is used to perform ultrasonic linear amplification on the waveform data, the impedance matching module is used to ensure the impedance matching between the signal source of the waveform data and the ultrasonic transducer as a load, and the ultrasonic transducer is used to finally output the generated ultrasound;

[0104] Wherein, the ultrasonic linear power amplifier includes a low-voltage signal buffer, a high-voltage linear amplifier, a feedback circuit and a protection circuit, such as Figure 4 As shown, specifically:

[0105] 1. The low-voltage signal buffer receives the signal from the programmable logic module FPGA, uses a high input impedance amplifier to prevent signal detail loss, and adjusts the amplification factor to 2 or 4 times by adjusting the low gain gain0;

[0106] 2. The high-voltage linear amplifier uses a linear amplifier circuit to provide high-quality signal amplification and required power output. The amplification factor is adjusted to 6 or 46 times by adjusting the high gain gain1, and the feedback circuit is used to stabilize the output;

[0107] 3. The protection circuit includes over-current and over-heat protection circuits to prevent the power amplifier from being damaged.

[0108] The interval stimulation mode implemented by the system reduces the continuous action time of ultrasound and reduces the thermal effect by inserting interval time during stimulation. The high-voltage programmable power supply used in the system can adjust the voltage provided to the power amplifier according to the required output voltage range, which can reduce the power consumption of the circuit and further ensure the safety of the circuit.

[0109] Most existing systems use fixed frequencies and waveforms, mainly using continuous waves or single pulse waveforms, which can easily lead to overheating and adaptability of nerve tissue. Advantages of this system: Multi-parameter regulation: provides multi-level voltage, frequency, duty cycle and waveform adjustment parameters to achieve more precise nerve regulation; Interval stimulation mode: effectively reduces thermal effects and improves safety; Frequency modulation wave: avoids nerve adaptability through dynamic frequency regulation and improves efficacy.

[0110] Regarding the effectiveness of the system of the present invention, taking a 0.5MHz transducer and a matching acoustic collimator as an example, the sound field test results are as follows: Figure 5 As shown, it can be seen that after the ultrasound is regulated by the acoustic collimator, the focal diameter of the sound field is about 1.5 mm, which can meet the high-resolution requirements of the transcranial ultrasound regulation experiment.

[0111] Second embodiment

[0112] like Figure 6 As shown, this embodiment provides a transcranial ultrasound stimulation method supporting interval and frequency modulation using the transcranial ultrasound stimulation system supporting interval and frequency modulation as in the first embodiment, comprising the following steps:

[0113] S1: The upper computer interaction module receives the excitation ultrasonic signal parameters configured by the user, generates control data as a high-precision signal according to the excitation ultrasonic signal parameters, and transmits the control data to the programmable logic module, wherein the excitation ultrasonic signal is configured by the user-defined configuration in a manner including an intelligent parameter selection mode and an autonomous setting mode;

[0114] S2: the programmable logic module receives the control data transmitted by the host computer interaction module, generates and configures the waveform data and the control signal according to the control data, and then sends the waveform data to the ultrasonic transmitting module in sequence at a fixed frequency;

[0115] S3: The ultrasonic transmitting module completes the digital-to-analog conversion of the waveform data, and after amplification by the ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output, and a power supply module is used to provide multiple working levels required during the operation of the system, as well as the high voltage required for high-voltage ultrasonic pulses, and the voltage is finely adjusted in multiple gears.

[0116] Third embodiment

[0117] This embodiment provides a specific example of the experiment on mice. Taking mouse a as an example, the photoacoustic imaging analysis results show that the photoacoustic signal attenuation at the injury site is 31.82%, the modified neurological function score is 10 points, the corner test CT score is 80%, and the severity is judged to be moderate. Figure 7 Shown are schematic diagrams of mice before and after injury.

[0118] The experiment was divided into two groups: the model group (PT group) and the control group (PT-LITUS group). All groups were mice judged to be of moderate severity. Figure 8 shown.

[0119] In this experiment, the recommended parameters of the intelligent parameter selection system are: the central frequency of transcranial ultrasound regulation is 0.5MHz, the duty cycle is 20%, the pulse repetition frequency is 1kHz, the sound intensity ISPPA = 1.66W / cm2, ISPTA = 332mW / cm2, the mechanical index MI = 0.744, and the maximum sound pressure is 223kPa (calibrated by hydrophone measurement). The LITUS treatment time is 20 minutes per day for 7 days. The pulse duration in the interval stimulation mode is 0.3 seconds, and the interval stimulation time is 2.7 seconds.

[0120] like Fig. 9 As shown in the figure, after LITUS manipulation, the movement distance in the open arm of the PT-LITUS group was significantly improved compared with the PT group.

[0121] like Fig.10 As shown, some cells in the prefrontal cortex of the PT group and the PT-LITUS group shrank, the PT group showed mild inflammatory cell infiltration, and the PT-LITUS group did not show obvious inflammatory cell infiltration.

[0122] like Fig.11 As shown, some cells in the prefrontal cortex of the PT group were wrinkled and darkly stained, and the neuronal damage in the PT-LITUS group was improved to a certain extent, but a small number of cells were still wrinkled and darkly stained.

[0123] HE staining can be used to evaluate the degree of inflammation in the stained area, and Nissl staining can be used to evaluate the damage of neurons. After photochemical embolization induced ischemic brain injury in mice, the mice in the PT group and PT-LITUS group had neuronal cell damage and inflammatory cell infiltration. Some cells in the PT group and PT-LITUS group shrank, and Nissl bodies were unevenly distributed. The PT group showed mild inflammatory cell infiltration. After LITUS regulation, the neuronal damage in the PT-LITUS group was improved to a certain extent, and a small number of cells were still shrunken and darkly stained, but no obvious inflammatory reaction was observed.

[0124] like Fig.12As shown in the figure, after LITUS regulation, the expression level of BDNF in the prefrontal cortex of the PT-LITUS group was significantly enhanced compared with that of the PT group. Brain-derived neurotrophic factor (BDNF) is one of the important members of the neurotrophin family. Studies have shown that BDNF is the most abundant neurotrophic factor in the brain and plays a key role in regulating neurogenesis, neuronal and microglial survival, and stimulating neuroplasticity and differentiation of central nervous system cells. Changes in BDNF expression are associated with psychiatric disorders, especially in brain regions related to memory, such as the hippocampus and parahippocampal regions, and BDNF upregulation can improve cognitive impairment in animal models of neurodegenerative diseases. BDNF can enhance synaptic plasticity and is considered to be directly related to learning and memory abilities. It may be a mediator of plasticity changes during spatial and recognition memory. Therefore, increasing the expression level of BDNF in the brain has a positive effect on neurological and functional recovery after brain injury.

[0125] like Fig.13 As shown in the figure, after LITUS regulation, the expression level of Iba1 in the PT-LITUS group was significantly decreased compared with the PT group. Iba1 is a key molecule of pro-inflammatory activity, involved in the process of activating microglia, and is widely used as a marker of microglia in the brain. Microglia are the main cell type that mediates neuroinflammation after stroke. After a stroke, a large number of activated microglia will exist around the damaged neurons. Microglia will secrete a large number of pro-inflammatory factors and chemokines, which will promote cell damage and neuronal death, and recruit immune cells to infiltrate the inflammatory center, further expanding the inflammatory response. The inflammatory response has strong neurotoxicity and leads to neurological deficits. Studies have shown that reducing the number of microglia can effectively prevent the occurrence of cognitive dysfunction.

[0126] The results of immunofluorescence staining of the prefrontal cortex, the target of LITUS regulation, showed that photochemical embolization-induced ischemic brain damage in mice led to a significant decrease in the expression level of BDNF and a significant increase in the expression level of Iba1 in the prefrontal cortex of mice, while LITUS regulation effectively increased the expression of BDNF in the PT-LITUS group and inhibited the expression of Iba1. This suggests that the transcranial ultrasound regulation system promotes the rehabilitation of cognitive impairment after stroke by enhancing BDNF expression and inhibiting inflammatory response.

[0127] A computer-readable storage medium stores a computer code. When the computer code is executed, the above method is executed. A person skilled in the art can understand that all or part of the steps in the various methods of the above embodiments can be completed by instructing related hardware through a program. The program can be stored in a computer-readable storage medium. The storage medium can include: a read-only memory (ROM), a random access memory (RAM), a disk or an optical disk, etc.

[0128] The above is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments. All technical solutions under the concept of the present invention belong to the protection scope of the present invention. It should be pointed out that for ordinary technicians in this technical field, some improvements and modifications without departing from the principle of the present invention should also be regarded as the protection scope of the present invention.

[0129] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0130] It should be noted that the above embodiments can be freely combined as needed. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered as the protection scope of the present invention.

Claims

1. A transcranial ultrasound stimulation system supporting interval and frequency modulation, characterized in that: include: Host computer interaction module, programmable logic module, ultrasonic transmission module and power supply module; The host computer interaction module is used to receive the excitation ultrasonic signal parameters of the custom configuration, and generate control data as a high-precision signal according to the excitation ultrasonic signal parameters, and transmit it to the programmable logic module, wherein the custom configuration of the excitation ultrasonic signal is configured in a manner including an intelligent parameter selection mode and an autonomous setting mode; The programmable logic module is used to receive the control data transmitted by the host computer interaction module, and after completing the generation and configuration of the waveform data and the control signal according to the control data, send the waveform data to the ultrasonic transmitting module in sequence at a fixed frequency; The ultrasonic transmitting module is used to complete the digital-to-analog conversion of the waveform data, and after amplification by the ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output; The power supply module is used to provide multiple operating levels required during the operation of the system, provide the high voltage required for the high-voltage ultrasonic pulse, and perform fine multi-level voltage regulation.

2. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 1, characterized in that: In the host computer interaction module, the excitation ultrasonic signal parameters of the custom configuration are received, and the control data as a high-precision signal is generated according to the excitation ultrasonic signal parameters, and transmitted to the programmable logic module, specifically: Providing a GUI interface for inputting the excitation ultrasound signal parameters, and adjusting the excitation ultrasound signal parameters including waveform, frequency, phase, amplitude, stimulation duration, output duration and interval duration of the interval stimulation mode through the GUI interface; After converting the excitation ultrasonic signal parameters into the control data, the data are transmitted to the programmable logic module via a serial peripheral interface UART protocol; The host computer interaction module displays the waveform sampling situation to adjust the excitation ultrasonic signal parameters according to the waveform sampling situation.

3. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 1, characterized in that: In the host computer interaction module, the intelligent parameter selection mode is used to set the excitation ultrasonic signal parameters, specifically: A: Building a treatment database: Collecting data: collecting experimental data and test results before and after treatment with different combinations of the excitation ultrasound signal parameters, including optical imaging results, neurological function scores, staining results, and inflammation reduction degrees; Establishing a scoring mechanism: setting scoring weights according to different indicators including the degree of inflammation relief, tissue recovery and pathological staining, and giving a treatment effect score for each combination of the excitation ultrasound signal parameters; B: Data Analysis Severity determination: The severity of the patient is determined based on optical imaging results, modified neurological function assessment, and corner test, and is divided into three categories: mild, moderate, and severe; Indicator weight setting: Setting weights for different treatment effect indicators including the degree of inflammation reduction, tissue recovery and pathological staining; Score calculation: calculating the comprehensive score of the corresponding combination of the excitation ultrasonic signal parameters according to the experimental data; C: Parameter selection Test data input: Input the patient's test data, including optical imaging results, behavioral experiment results, and neurological function scores; Score matching: matching the combination of the excitation ultrasound signal parameters in the treatment database according to the input data, and selecting the combination of the excitation ultrasound signal parameters with the highest score.

4. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 3, characterized in that: The severity determination is specifically: The optical imaging result: the photoacoustic signal intensity of the damaged area before and after the damage is analyzed, and the photoacoustic signal intensity of the damaged area before the damage is used as the reference value, and the photoacoustic signal attenuation degree of the damaged area after the damage is calculated as |Iafter damage-Ibefore damage| / Ibefore damage*100%; The improved neurological function assessment: conducting experiments on neurological deficits including tail lifting test, walking test, sensory test, balance beam test, reflex and abnormal movement, scoring different test results respectively and accumulating them; The corner turning test is used to evaluate sensorimotor disorders caused by unilateral or asymmetric striatal damage, measure asymmetric sensorimotor disorders and detect unilateral abnormalities of sensory and motor functions in ischemic stroke models. Several consecutive corner turning tests are performed. The CT score of the corner turning test = [R / (R+L)] × 100%, where R is the number of right turns; L is the number of left turns; The severity is classified into three categories: mild, moderate and severe, based on a comprehensive judgment made according to the optical imaging results, the modified neurological function assessment and the weight of the angle test.

5. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 2, characterized in that: In the host computer interaction module, the autonomous setting mode is used to set the excitation ultrasonic signal parameters, specifically: Performing autonomous parameter setting on the GUI interface provided by the host computer interaction module; Among them, the target frequency f_wave is the ultrasonic frequency of the excitation, the minute setting and the second setting are the minutes and seconds corresponding to the total stimulation duration, PRF is the pulse repetition frequency, DC is the duty cycle, wake time and sleep time correspond to the output duration and interval duration in the interval stimulation mode respectively, gain1 and gain0 correspond to the gain control of the two-stage amplifier circuit in the ultrasonic linear amplifier circuit, where gain1 represents high gain and gain0 represents low gain. The size of the quantized waveform data is controlled by setting wave_amp; At the same time, the autonomous setting mode includes a fixed frequency ultrasonic output mode and a frequency modulation ultrasonic output mode. The target frequency of the fixed frequency ultrasonic output mode is a fixed value, and the target frequency of the frequency modulation ultrasonic output mode needs to set the initial frequency f0 and the end frequency fe, as well as the duration of a cycle.

6. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 5, characterized in that: The ultrasonic transmitting module includes a digital-to-analog converter, an ultrasonic linear power amplifier, an impedance matching device and an ultrasonic transducer; The digital-to-analog conversion is used to complete the digital-to-analog conversion of the waveform data, the ultrasonic linear power amplifier is used to perform ultrasonic linear amplification on the waveform data, the impedance matching is used to ensure the impedance matching between the signal source of the waveform data and the ultrasonic transducer as a load, and the ultrasonic transducer is used to finally output the generated ultrasound; Among them, the ultrasonic linear power amplifier includes a low-voltage signal buffer, a high-voltage linear amplifier, a feedback circuit and a protection circuit. The low-voltage signal buffer receives the signal from the programmable logic module, adopts a high input impedance amplifier to prevent signal detail loss, and adjusts the amplification factor to 2 or 4 times by adjusting the low gain gain0. The high-voltage linear amplifier uses a linear amplification circuit to provide high-quality signal amplification and required power output. The amplification factor is adjusted to 6 or 46 times by adjusting the high gain gain1. The feedback circuit is used to stabilize the output. The protection circuit includes overcurrent and overheating protection circuits to prevent damage to the power amplifier.

7. The transcranial ultrasound stimulation system supporting interval and frequency modulation according to claim 1, characterized in that: The power supply module includes a low-voltage power supply and a high-voltage programmable power supply; The low-voltage power supply is used to provide multiple working levels required during the operation of the system, and the high-voltage programmable power supply is controlled by an external control voltage or program code to provide the high voltage required for high-voltage ultrasonic pulses and to finely adjust the voltage in multiple levels.

8. A transcranial ultrasound stimulation method supporting interval and frequency modulation using the transcranial ultrasound stimulation system supporting interval and frequency modulation as described in claims 1-7, characterized in that: The following steps are involved: S1: The upper computer interaction module receives the excitation ultrasonic signal parameters configured by the user, generates control data as a high-precision signal according to the excitation ultrasonic signal parameters, and transmits the control data to the programmable logic module, wherein the excitation ultrasonic signal is configured by the user-defined configuration in a manner including an intelligent parameter selection mode and an autonomous setting mode; S2: the programmable logic module receives the control data transmitted by the host computer interaction module, generates and configures the waveform data and the control signal according to the control data, and then sends the waveform data to the ultrasonic transmitting module in sequence at a fixed frequency; S3: The ultrasonic transmitting module completes the digital-to-analog conversion of the waveform data, and after amplification by the ultrasonic linear amplifier chip, it is loaded onto the ultrasonic transducer for output, and a power supply module is used to provide multiple working levels required during the operation of the system, as well as the high voltage required for high-voltage ultrasonic pulses, and the voltage is finely adjusted in multiple gears.

9. A computer device comprising a memory and one or more processors, wherein the memory stores computer codes, and when the computer codes are executed by the one or more processors, the one or more processors execute the method according to any one of claims 8. 10 . A computer-readable storage medium storing a computer code, wherein when the computer code is executed, the method according to claim 8 is executed.

Citation Information

Cited By

  • Ultrasonic transducer excitation circuit and ultrasonic transducer

    CN120023086A

  • Adaptive closed-loop ultrasonic stimulation system and method based on Actor-Critic reinforcement learning

    CN121266027A